SRDX (Surmodics) Marketable Securities: $6.4 Mil (As of Jun. 2025)


SRDX Surmodics Inc SRDX
51 GF Score
Price $42.98
View Full Analysis

What is Surmodics Marketable Securities?

Surmodics SRDX -0.01% 51 Marketable Securities is $6.4 Mil as of Jun. 2025. GuruFocus rates SRDX with a GF Score™ of 51/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Surmodics's Marketable Securities for the quarter that ended in Jun. 2025 was $6.4 Mil.

Surmodics's annual Marketable Securities increased from Sep. 2022 ($0.0 Mil) to Sep. 2023 ($3.9 Mil) and increased from Sep. 2023 ($3.9 Mil) to Sep. 2024 ($4.0 Mil).

Surmodics  (NAS:SRDX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Surmodics Marketable Securities Related Terms

Surmodics Marketable Securities Historical Data

* Premium members only.

The historical data trend for Surmodics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics Marketable Securities Chart

Surmodics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.31 7.72 0.00 3.93 4.00

Surmodics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.87 4.00 0.00 1.97 6.45
SRDX
51GF Score
Surmodics Inc SRDX
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surmodics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $6.4 Mil mean?
Surmodics (SRDX) has a Marketable Securities of $6.4 Mil as of Jun. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Surmodics and its competitors.
Is Surmodics' Marketable Securities too high?
Surmodics' current Marketable Securities is $6.4 Mil. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' Marketable Securities compare to CBLL and OFIX?
Surmodics' Marketable Securities of $6.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Surmodics and its competitors. Surmodics's current Marketable Securities is $6.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current Marketable Securities of $6.4 Mil. The current Marketable Securities is $6.4 Mil. Surmodics' overall GF Score™ is 51/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Surmodics (SRDX), the current Marketable Securities is $6.4 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Surmodics Business Description

Address 9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score

Get the complete analysis for SRDX

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.98
Price